BRAIN Biotech AG Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	6.19	27.17	5.35	8.44	24.55
Short-Term Investments	0.13	0.06	0.06	0.08	0.06
Cash & Short-Term Investments	6.32	27.23	5.41	8.53	24.6
Cash Growth	-76.81%	403.59%	-36.58%	-65.35%	29.50%
Accounts Receivable	8.46	7.8	9.44	8.04	6.72
Other Receivables	0.42	0.32	0.27	3.24	0.13
Receivables	9	8.24	9.83	11.35	6.95
Inventory	8.94	9.42	9.76	9.66	7.02
Prepaid Expenses	0.6	0.6	0.39	0.33	0.32
Other Current Assets	0.11	0.17	0.09	0.52	0.23
Total Current Assets	24.96	45.66	25.48	30.38	39.11
Property, Plant & Equipment	27.55	27.86	28.72	28.74	24.29
Long-Term Investments	1.28	0.97	1.46	1.94	0.55
Goodwill	6.63	6.81	6.67	6.61	4.73
Other Intangible Assets	5.87	7.38	8.55	10.16	8.81
Long-Term Deferred Charges	0.06	0.07	0.02	0.06	-
Other Long-Term Assets	0	-	-	0.01	0.1
Total Assets	66.34	88.74	70.94	77.99	77.74
Accounts Payable	4.36	5.61	5.62	6.75	3.83
Accrued Expenses	2.8	5.91	3.6	2.67	2.28
Current Portion of Long-Term Debt	6.22	7.41	2.26	1.43	1.24
Current Portion of Leases	1.72	1.57	1.44	1.27	1.08
Current Income Taxes Payable	-	-	0.04	0.17	0.06
Current Unearned Revenue	1.13	0.62	2.93	1.99	1.57
Other Current Liabilities	1.38	3.89	1.59	7.1	1.27
Total Current Liabilities	17.6	25.01	17.48	21.39	11.34
Long-Term Debt	5.51	10.71	-	2.62	3.48
Long-Term Leases	7.29	6.62	6.74	5.41	5.58
Long-Term Unearned Revenue	0.38	1.12	0.52	0.77	1.11
Pension & Post-Retirement Benefits	0.7	0.93	0.93	1.15	2.27
Long-Term Deferred Tax Liabilities	3.35	3.88	3.77	3.29	2.79
Other Long-Term Liabilities	29.67	26.59	18.49	9.11	9.35
Total Liabilities	64.5	74.85	47.92	43.74	35.91
Common Stock	21.85	21.85	21.85	21.85	21.85
Additional Paid-In Capital	95.73	94.95	93.46	92.66	95.89
Retained Earnings	-116.04	-105.49	-94.16	-85.2	-79.51
Comprehensive Income & Other	0.3	1.31	0.63	0.33	0.56
Total Common Equity	1.84	12.62	21.77	29.64	38.78
Minority Interest	-	1.27	1.24	4.61	3.04
Shareholders' Equity	1.84	13.89	23.01	34.25	41.83
Total Liabilities & Equity	66.34	88.74	70.94	77.99	77.74
Total Debt	20.73	26.3	10.44	10.74	11.38
Net Cash (Debt)	-14.42	0.93	-5.03	-2.21	13.22
Net Cash Growth	-	-	-	-	123.82%
Net Cash Per Share	-0.66	0.04	-0.23	-0.10	0.66
Filing Date Shares Outstanding	21.85	21.85	21.85	21.85	21.85
Total Common Shares Outstanding	21.85	21.85	21.85	21.85	21.85
Working Capital	7.36	20.65	8	9	27.78
Book Value Per Share	0.08	0.58	1.00	1.36	1.78
Tangible Book Value	-10.65	-1.57	6.56	12.87	25.25
Tangible Book Value Per Share	-0.49	-0.07	0.30	0.59	1.16
Land	10.47	10.66	10.42	10.33	16.26
Machinery	21.7	22.19	21.55	22.68	20.59
Construction In Progress	1.02	0.19	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.